---
schema_version: "secwatch.filing_event.v1"
accession: "0001295947-22-000007"
form_type: "8-K"
ticker: "PBH"
cik: "0001295947"
company_name: "Prestige Consumer Healthcare Inc."
filed_at: "2022-02-03T23:59:59+00:00"
generated_at: "2026-06-27T11:33:38.252443+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.78
calibrated_materiality_score: 0.78
confidence: "high"
source: SEC EDGAR
---

# Prestige Q3 revenue $274.5M (+14.9% YoY), EPS $0.99 (+22.2%); raises FY22 outlook

## Summary
- Revenue $274.5M, up 14.9% YoY; organic growth 8.8% excluding currency and Akorn acquisition.
- Diluted EPS $0.99, up 22.2% YoY; FY22 adjusted diluted EPS guidance raised to $4.00-$4.04.
- Non-GAAP free cash flow $64.1M in Q3 vs $43.5M prior year; FY22 free cash flow guidance raised to $250M+.
- North America OTC segment $240.9M (+14.4%); International OTC $33.6M (+19.3% record).
- Paid down $70M debt in Q3; net debt ~$1.5B, covenant leverage ratio 3.9x.

## SEC filing metadata
- accession: 0001295947-22-000007
- form_type: 8-K
- ticker: PBH
- cik: 0001295947
- company_name: Prestige Consumer Healthcare Inc.
- filed_at: 2022-02-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.78
- calibrated_materiality_score: 0.78
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1295947/000129594722000007/0001295947-22-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1295947/000129594722000007/pbh-20220203.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001295947-22-000007
- JSON: https://secwatch.observer/filing/0001295947-22-000007.json
- Plain text: https://secwatch.observer/filing/0001295947-22-000007.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.